genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Primers
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Drug Delivery
Nanomaterial Targets Obesity, Shrinks Local Fat Depots by Rejuvenating Healthy, “Dwarf”…
Drug Discovery
mRNA Vaccines Show Promise against Malaria
News
Global Phenotypes of Chromosome Gain Justifies Alternative View of Down Syndrome
Antibodies
HIV Vaccine Clinical Trial Provides Promising Results
Blood Disorders
3D Organoid Model Developed for Gastroesophageal Junction Cancer
Insights
All
Trends for 2020
Trends for 2021
Antibodies
Biosimilars and Diversification Drive Innovation in mAb Manufacturing
Bioprocessing
Biopharma Facility Planning Improves with Monte Carlo Simulation Modeling
Bioprocessing
Bioprocessing Gets a Jolt
Bioprocessing
Advanced Biotherapy Regulatory Considerations
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Primers
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Authors
Posts by
36633 POSTS
2 COMMENTS
Dr. Jonathan Grinstein (jgrinstein@liebertpub.com) is a Senior Editor to GEN's parent company Mary Ann Liebert, Inc.
Artificial Intelligence
Turbine Announces €20-Million Series A behind Digital Cell Platform
Genome Editing
Mining (and Refining) the Stuff of Gene Editing Tools
Artificial Intelligence
Biopharma Soars to the Computational Clouds
Companies
At Illumina Genomics Forum, Obama Prescribes Diversity, Resilience to Drive Precision...
Genome Editing
CRISPR Technology Turns 10, Rises to New Challenges
Scroll Up
Login
Subscribe
